0

    537536

    DENISCHEM

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    DENIS CHEM LAB LTD Share Price Today

    Investment Returns

    Over 1 Month 14.96% Over 3 Months 10.18% Over 6 Months -2.34% Over 1 Year -18.23%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    DENIS CHEM LAB LTD fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 111.20
    • P/E Ratio (TTM) 13.51
    • Beta 0.81
    • Book Value / share 65.99
    • Return on equity 9.77%
    • EPS (TTM) 6.06
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.40
    info icon alternate text

    DENIS CHEM LAB LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 46.75
    Operating Expense 46.15
    Net Profit 0.40
    Net Profit Margin (%) 0.85
    Earnings Per Share (EPS) 0.29
    EBITDA 3.08
    Effective Tax Rate (%) 64.91
    Particulars DEC 2025 (Values in Cr)
    Revenue 45.52
    Operating Expense 41.55
    Net Profit 3.32
    Net Profit Margin (%) 7.29
    Earnings Per Share (EPS) 2.39
    EBITDA 6.46
    Effective Tax Rate (%) 24.71
    Particulars SEP 2025 (Values in Cr)
    Revenue 46.17
    Operating Expense 43.79
    Net Profit 2.21
    Net Profit Margin (%) 4.78
    Earnings Per Share (EPS) 1.60
    EBITDA 4.91
    Effective Tax Rate (%) 26.73
    Particulars JUN 2025 (Values in Cr)
    Revenue 43.28
    Operating Expense 40.26
    Net Profit 2.48
    Net Profit Margin (%) 5.73
    Earnings Per Share (EPS) 1.78
    EBITDA 7.09
    Effective Tax Rate (%) 25.30
    Particulars MAR 2025 (Values in Cr)
    Revenue 41.38
    Operating Expense 41.29
    Net Profit 0.71
    Net Profit Margin (%) 1.71
    Earnings Per Share (EPS) 0.51
    EBITDA 3.23
    Effective Tax Rate (%) 44.09
    Particulars MAR 2026 (Values in Cr)
    Revenue 181.72
    Operating Expense 171.75
    Net Profit 8.41
    Net Profit Margin (%) 4.62
    Earnings Per Share (EPS) 6.06
    EBITDA 19.58
    Effective Tax Rate (%) 29.32
    Particulars MAR 2025 (Values in Cr)
    Revenue 173.30
    Operating Expense 164.56
    Net Profit 8.08
    Net Profit Margin (%) 4.66
    Earnings Per Share (EPS) 5.82
    EBITDA 18.48
    Effective Tax Rate (%) 27.36
    Particulars MAR 2024 (Values in Cr)
    Revenue 167.82
    Operating Expense 154.07
    Net Profit 11.16
    Net Profit Margin (%) 6.64
    Earnings Per Share (EPS) 8.04
    EBITDA 22.62
    Effective Tax Rate (%) 26.30
    Particulars MAR 2023 (Values in Cr)
    Revenue 160.85
    Operating Expense 150.51
    Net Profit 7.86
    Net Profit Margin (%) 4.88
    Earnings Per Share (EPS) 5.66
    EBITDA 19.38
    Effective Tax Rate (%) 28.02
    Particulars MAR 2022 (Values in Cr)
    Revenue 136.56
    Operating Expense 128.72
    Net Profit 6.26
    Net Profit Margin (%) 4.58
    Earnings Per Share (EPS) 4.51
    EBITDA 15.40
    Effective Tax Rate (%) 29.50
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 61.33
    ROE % 9.77
    ROCE % 13.83
    Total Debt to Total Equity 0.01
    EBITDA Margin 10.66
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 57.91
    ROE % 14.62
    ROCE % 20.07
    Total Debt to Total Equity 0.02
    EBITDA Margin 13.48
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 52.08
    ROE % 11.33
    ROCE % 15.98
    Total Debt to Total Equity 0.04
    EBITDA Margin 12.04
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 47.89
    ROE % 9.78
    ROCE % 13.60
    Total Debt to Total Equity 0.09
    EBITDA Margin 11.28
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 44.32
    ROE % 3.75
    ROCE % 6.36
    Total Debt to Total Equity 0.18
    EBITDA Margin 9.70
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 26.23
    Total Assets 112.27
    Total Liabilities 112.27
    Total Equity 85.10
    Share Outstanding 1
    Price to Book Ratio 1.51
    Return on Assets (%) 7.19
    Return on Capital (%) 9.4
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 25.14
    Total Assets 109.34
    Total Liabilities 109.34
    Total Equity 80.36
    Share Outstanding 1
    Price to Book Ratio 2.60
    Return on Assets (%) 10.20
    Return on Capital (%) 13.7
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 16.93
    Total Assets 99.44
    Total Liabilities 99.44
    Total Equity 72.26
    Share Outstanding 1
    Price to Book Ratio 1.22
    Return on Assets (%) 7.90
    Return on Capital (%) 10.59
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 8.82
    Total Assets 96.38
    Total Liabilities 96.38
    Total Equity 66.45
    Share Outstanding 1
    Price to Book Ratio 1.42
    Return on Assets (%) 6.49
    Return on Capital (%) 8.99
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 4.54
    Total Assets 92.26
    Total Liabilities 92.26
    Total Equity 61.50
    Share Outstanding 1
    Price to Book Ratio 0.84
    Return on Assets (%) 2.45
    Return on Capital (%) 3.23
    Particulars MAR 2025 (Values in Cr)
    Net Income 11.11
    Cash from Operations 16.97
    Cash from Investing -8.22
    Cash from Financing -4.20
    Net change in Cash -0.34
    Free Cash Flow 16.97
    Particulars MAR 2024 (Values in Cr)
    Net Income 15.13
    Cash from Operations 22.15
    Cash from Investing -14.89
    Cash from Financing -4.20
    Net change in Cash -1.28
    Free Cash Flow 22.15
    Particulars MAR 2023 (Values in Cr)
    Net Income 10.91
    Cash from Operations 18.73
    Cash from Investing -11.15
    Cash from Financing -4.00
    Net change in Cash 1.17
    Free Cash Flow 18.73
    Particulars MAR 2022 (Values in Cr)
    Net Income 8.88
    Cash from Operations 18.15
    Cash from Investing -10.13
    Cash from Financing -7.20
    Net change in Cash -0.26
    Free Cash Flow 18.15
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.08
    Cash from Operations 8.68
    Cash from Investing -1.12
    Cash from Financing -5.50
    Net change in Cash 1.33
    Free Cash Flow 8.68
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 13.24 1.55 245.46 23.12 38.85
    BLISS GVS PHARMA LTD 511.55 41.12 4.54 5425.31 118.35 552.90
    CIPLA LTD. 1452.35 30.82 3.40 117327.41 1165.55 1672.20
    FERMENTA BIOTECH LTD. 369.50 16.30 2.67 1087.47 256.40 401.20
    GLAXOSMITHKLINE PHARMA LT 2402.90 42.30 17.95 40706.58 2088.00 3356.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 22.40 4.12 245.46 23.12 38.85
    AMRUTAJAN HEALTH LTD 538.95 24.16 4.20 1558.14 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8200.05 107.09 23.48 20500.13 7630.00 9850.00
    BLISS GVS PHARMA LTD 511.55 55.30 4.69 5425.31 118.35 552.90

    DENIS CHEM LAB LTD shareholding pattern

    Holding
    61.01%
    38.98%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    DENIS CHEM LAB LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    80.16 -2.11 redarrow
    red-green-graph indicator
    1 Bearish
    15 Bullish
    • 5 Days 79.20
    • 26 Days 74.90
    • 10 Days 77.10
    • 50 Days 74.50
    • 12 Days 76.60
    • 100 Days 75.60
    • 20 Days 75.40
    • 200 Days 82.50
    81.80 PIVOT
    First Support 79.59 First Resistance 84.09 Second Support 77.30 Second Resistance 86.30 Third Support 75.09 Third Resistance 88.59
    RSI 67.69 ADX 16.25 MACD 1.62 Williams % R -22.79 Commodity Channel Index (CCI) 286.43
    Date 2026-07-07 Week 13952.00 Same Day 21299.00 Month 6467.00
    1 Year 0.82 3 Year 0.97
    Over 1 Month
    14.96% down
    Over 1 Year
    -18.23% down
    Over 3 Months
    10.18% down
    Over 3 Years
    -2.47% down
    Over 6 Months
    -2.34% down
    Over 5 Years
    8.16% down

    DENIS CHEM LAB LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2025 1.5 Final 19 Sep 2025 Equity shares
    19 Sep 2024 2.5 Final 20 Sep 2024 Equity shares
    22 Sep 2023 2.0 Final 23 Sep 2023 Equity shares
    20 Sep 2022 1.5 Final 22 Sep 2022 Equity shares
    20 Sep 2021 0.75 Final 22 Sep 2021 Equity shares
    18 Sep 2019 1.0 Final 20 Sep 2019 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Denis Chem Lab Ltd?

    Answer Field

    Denis Chem Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 80.16 as on Jul 08 2026 03:28 PM.

    What is the Market Cap of Denis Chem Lab Ltd Share?

    Answer Field

    The market cap of Denis Chem Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 111.20 as on Jul 08 2026 03:28 PM.

    What is the 52 Week High and Low of Denis Chem Lab Ltd?

    Answer Field

    The 52 Week High and Low of Denis Chem Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 104.75 and ₹ 56.10.

    What is 1 year return for Denis Chem Lab Ltd?

    Answer Field

    The 1 year returns on the stock has been -18.23%.

    What is the P/E Ratio of Denis Chem Lab Ltd Share?

    Answer Field

    As on Jul 08 2026 03:28 PM the price-to-earnings (PE) ratio for Denis Chem Lab Ltd share is 13.51.

    What is the PB ratio of Denis Chem Lab Ltd Share?

    Answer Field

    As on Jul 08 2026 03:28 PM, the price-to-book (PB) ratio for Denis Chem Lab Ltd share is 65.99.

    How to Buy Denis Chem Lab Ltd Share?

    Answer Field

    You can trade in Denis Chem Lab Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Denis Chem Lab Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Denis Chem Lab Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Denis Chem Lab Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |